GenMark Diagnostics Net Income 2010-2019 | GNMK

GenMark Diagnostics net income from 2010 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
GenMark Diagnostics Annual Net Income
(Millions of US $)
2018 $-51
2017 $-62
2016 $-51
2015 $-42
2014 $-38
2013 $-34
2012 $-22
2011 $-24
2010 $-18
2009 $-20
GenMark Diagnostics Quarterly Net Income
(Millions of US $)
Q3 2019 $-12
Q2 2019 $-13
Q1 2019 $-12
Q4 2018 $-12
Q3 2018 $-11
Q2 2018 $-17
Q1 2018 $-11
Q4 2017 $-15
Q3 2017 $-15
Q2 2017 $-18
Q1 2017 $-14
Q4 2016 $-13
Q3 2016 $-12
Q2 2016 $-13
Q1 2016 $-13
Q4 2015 $-9
Q3 2015 $-11
Q2 2015 $-12
Q1 2015 $-10
Q4 2014 $-9
Q3 2014 $-10
Q2 2014 $-11
Q1 2014 $-9
Q4 2013 $-11
Q3 2013 $-11
Q2 2013 $-8
Q1 2013 $-4
Q4 2012 $-5
Q3 2012 $-6
Q2 2012 $-6
Q1 2012 $-6
Q4 2011 $-5
Q3 2011 $-6
Q2 2011 $-6
Q1 2011 $-7
Q4 2010 $-4
Q3 2010 $-5
Q2 2010 $-5
Q1 2010 $-5
Q4 2009 $-6
Q3 2009 $-6
Q2 2009 $-4
Q1 2009 $-4
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.314B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $127.547B 26.42
Intuitive Surgical (ISRG) United States $66.430B 52.21
Edwards Lifesciences (EW) United States $48.038B 43.62
Fresenius Medical Care AG KGaA (FMS) Germany $21.889B 14.81
IDEXX Laboratories (IDXX) United States $21.484B 51.96
Olympus (OCPNY) Japan $20.008B 150.26
DexCom (DXCM) United States $19.437B 174.07
Teleflex (TFX) United States $16.425B 33.34
Sysmex ADR (SSMXY) Japan $14.351B 38.63
SONOVA HOLDING (SONVY) Switzerland $14.289B 0.00
Hologic (HOLX) United States $14.104B 21.56
STERIS (STE) Ireland $13.029B 28.78
Varian Medical Systems (VAR) United States $12.655B 30.00
Masimo (MASI) United States $8.225B 49.11
ABIOMED (ABMD) United States $8.077B 43.95
Globus Medical (GMED) United States $5.655B 34.90
SARTORIUS AG (SARTF) Germany $5.614B 49.28
Penumbra (PEN) United States $5.470B 178.03
Integra LifeSciences Holdings (IART) United States $5.260B 22.60
Elekta AB (EKTAY) Sweden $4.707B 36.24
LivaNova (LIVN) United Kingdom $3.814B 27.46
Wright Medical Group (WMGI) Netherlands $3.744B 226.92
Tandem Diabetes Care (TNDM) United States $3.562B 0.00
Nevro (NVRO) United States $3.353B 0.00
Cantel Medical (CMD) United States $3.129B 30.63
Integer Holdings (ITGR) United States $2.568B 17.58
Nihon Kohden (NHNKY) Japan $2.401B 24.16
Glaukos (GKOS) United States $2.087B 0.00
Inogen (INGN) United States $1.575B 49.73
AVANOS MEDICAL, INC (AVNS) United States $1.572B 30.93
Veracyte (VCYT) United States $1.401B 0.00
Tactile Systems Technology (TCMD) United States $1.242B 141.85
Silk Road Medical (SILK) United States $1.076B 0.00
Natus Medical (NTUS) United States $1.063B 25.55
Mesa Laboratories (MLAB) United States $1.046B 38.76
OPKO Health (OPK) United States $1.005B 0.00
CryoLife (CRY) United States $0.972B 99.65
Luminex (LMNX) United States $0.941B 0.00
Accelerate Diagnostics (AXDX) United States $0.868B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.857B 28.47
Pacific Biosciences Of California (PACB) United States $0.817B 0.00
AxoGen (AXGN) United States $0.660B 0.00
Intersect ENT (XENT) United States $0.659B 0.00
OrthoPediatrics (KIDS) United States $0.595B 0.00
AngioDynamics (ANGO) United States $0.583B 20.95
Quotient (QTNT) Switzerland $0.577B 0.00
Si-Bone (SIBN) United States $0.460B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.457B 13.82
ViewRay (VRAY) United States $0.423B 0.00
Sientra (SIEN) United States $0.418B 0.00
Alphatec Holdings (ATEC) United States $0.399B 0.00
Stereotaxis (STXS) United States $0.299B 0.00
Semler Scientific (SMLR) United States $0.293B 40.82
IRadimed (IRMD) United States $0.275B 38.56
Accuray (ARAY) United States $0.251B 0.00
CRH Medical (CRHM) Canada $0.244B 68.00
SeaSpine Holdings (SPNE) United States $0.229B 0.00
Fluidigm (FLDM) United States $0.204B 0.00
RTI Surgical (RTIX) United States $0.163B 44.20
EDAP TMS S.A (EDAP) France $0.133B 35.38
Spectral Diagnostics (EDTXF) Canada $0.133B 0.00
Restoration Robotics (VERO) Canada $0.133B 0.00
ConforMIS (CFMS) United States $0.107B 0.00
Second Sight Medical Products (EYES) United States $0.098B 0.00
Neuronetics (STIM) United States $0.084B 0.00
Vermillion (VRML) United States $0.073B 0.00
Electromed (ELMD) United States $0.072B 25.67
Apollo Endosurgery (APEN) United States $0.063B 0.00
Sensus Healthcare (SRTS) United States $0.061B 0.00
T2 Biosystems (TTOO) United States $0.056B 0.00
Bioanalytical Systems (BASI) United States $0.046B 0.00
Ekso Bionics Holdings (EKSO) United States $0.043B 0.00
TransEnterix (TRXC) United States $0.042B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.038B 0.00
Neovasc (NVCN) Canada $0.025B 0.00
Xtant Medical Holdings (XTNT) United States $0.022B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.019B 0.00
ReWalk Robotics (RWLK) Israel $0.019B 0.00
DarioHealth (DRIO) Israel $0.016B 0.00
American Shared Hospital Services (AMS) United States $0.015B 20.83
OBALON THERPTCS (OBLN) United States $0.014B 0.00
Helius Medical Technologies (HSDT) United States $0.014B 0.00
Avinger (AVGR) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Ra Medical Systems (RMED) United States $0.012B 0.00
Lianluo Smart (LLIT) China $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.007B 0.00
Dynatronics (DYNT) United States $0.006B 0.00
Allied Healthcare Products (AHPI) United States $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.003B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00